Plasticell company
Plasticell is a privately held biotechnology company using novel cell culture and drug discovery platforms to produce regenerative small molecule drugs.
Plasticell aims to develop drugs by elucidating the biochemical mechanisms that control the proliferation and differentiation of stem cells, the master cells responsible for tissue development and repair.
Estimated Revenue:
$1M to $10M
Funding Status:
N/A
Industry:
Regenerative Medicine
Investors Number:
1
Number Of Exists:
Venture - Series Unknown
Technology:
Regenerative Medicine
Founded Date:
6-24
Investor Type:
Company
Headquarters:
London, England, United Kingdom
Total Funding:
£4.2M
Last Funding Type:
Venture - Series Unknown
Employee Number:
11-50
Investment Stage:
N/A